Results 231 to 240 of about 49,344 (290)

Cardiorenal safety and efficacy of angiotensin receptor-neprilysin inhibitors in heart failure across the ejection fraction spectrum: A meta-analysis and meta-regression of RCTs with 28,001 patients. [PDF]

Biomed Rep
Rampengan DDCH, Surya SC, Tjandra KC, Lele JAJMN, Rampengan SH, Kadariswantiningsih IN, Idrisov B, Idrisova A, Empitu MA.   +8 more
europepmc   +1 more source

Prevalence, recurrence, risk factors and adverse clinical outcomes of hyperkalemia in maintenance hemodialysis patients. [PDF]

BMC Nephrol
Liao W, Luo M, Zhang L, Ye H, Xu N, Liang Y, Zhuang L, Li H, Han Q, Mo C, Zhu Y, Yang Q.   +11 more
europepmc   +1 more source

BRASH syndrome: a systematic review of clinical manifestations and associated risk factors. [PDF]

World J Emerg Med
Tomulescu SA, Bavestrello Piccini G, Niță C, Stoian A, Longhitano Y, Planinsic R, Caputo G, Tesauro M, Voza A, Zanza C.   +9 more
europepmc   +1 more source

Hyperkalemia-related mortality trends in cardiac arrest: a 1999-2020 analysis in the United States. [PDF]

Ann Med Surg (Lond)
Akhter J, Abdul Ahad T, Riaz S, Ahmed R, Sathian B, Hussain A.   +5 more
europepmc   +1 more source

Hyperkalemia in Heart Failure with Reduced Ejection Fraction: Implications and Management. [PDF]

Heart Fail Rev
Beavers CJ, Greene SJ.
europepmc   +1 more source

Efficacy and Safety of Finerenone in Kidney Transplant Patients. [PDF]

J Clin Med
Kahvecioglu S, Celik H, Yalcinkaya AS, Ayar Y, Aktas N, Akarsu O.   +5 more
europepmc   +1 more source

Relationship between a diagnosis of kidney failure and heart diseases in patients with hyperkalemia

Darbà, Josep, Ascanio, Meritxell, Agüera, Ainoa   +2 more
openalex   +1 more source